Efforts in the research lab of Jörg Gerlach, MD, focus on liver cell transplantation for people with end-stage chronic liver failure.
Although liver cell transplant holds the promise of bridging people with liver failure to whole liver transplant, suitable cell populations are debatable.
Other cell sources we’re studying for initial clinical work include mesenchymal stem cells and hematopoietic stem cells.
McGowan Institute for Regenerative Medicine
450 Technology Drive
Pittsburgh, PA 15219